Trial reports transplant success in dyskeratosis congenita, a rare bone marrow failure syndrome, following conditioning with immunosuppressive drugs alone Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients w…
Source:Researchers report promising outcomes from clinical trial in patients with dyskeratosis congenita
Monday, December 8, 2014
Researchers report promising outcomes from clinical trial in patients with dyskeratosis congenita
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment